HomeCompareAFFCF vs ABBV

AFFCF vs ABBV: Dividend Comparison 2026

AFFCF yields 962.00% · ABBV yields 3.12%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AFFCF wins by $13454980.35M in total portfolio value
10 years
AFFCF
AFFCF
● Live price
962.00%
Share price
$0.21
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$13454980.46M
Annual income
$11,170,729,541,083.21
Full AFFCF calculator →
ABBV
AbbVie Inc.
● Live price
3.12%
Share price
$213.22
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$104.7K
Annual income
$25,725.73
Full ABBV calculator →

Portfolio growth — AFFCF vs ABBV

📍 AFFCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAFFCFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AFFCF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AFFCF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AFFCF
Annual income on $10K today (after 15% tax)
$81,770.08/yr
After 10yr DRIP, annual income (after tax)
$9,495,120,109,920.73/yr
ABBV
Annual income on $10K today (after 15% tax)
$265.10/yr
After 10yr DRIP, annual income (after tax)
$21,866.87/yr
At 15% tax rate, AFFCF beats the other by $9,495,120,088,053.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AFFCF + ABBV for your $10,000?

AFFCF: 50%ABBV: 50%
100% ABBV50/50100% AFFCF
Portfolio after 10yr
$6727490.28M
Annual income
$5,585,364,783,404.46/yr
Blended yield
83.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

AFFCF
No analyst data
Altman Z
52.7
Piotroski
1/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+20.1% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AFFCF buys
0
ABBV buys
0
No recent congressional trades found for AFFCF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAFFCFABBV
Forward yield962.00%3.12%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$13454980.46M$104.7K
Annual income after 10y$11,170,729,541,083.21$25,725.73
Total dividends collected$13279477.08M$63.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AFFCF vs ABBV ($10,000, DRIP)

YearAFFCF PortfolioAFFCF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$106,900$96,200.10$11,559$438.51+$95.3KAFFCF
2$1,075,486$961,102.76$13,494$640.86+$1.06MAFFCF
3$10,187,528$9,036,758.10$15,951$945.97+$10.17MAFFCF
4$90,901,208$80,000,552.76$19,152$1,413.89+$90.88MAFFCF
5$764,393,644$667,129,351.79$23,443$2,146.38+$764.37MAFFCF
6$6,060,826,681$5,242,925,482.22$29,391$3,321.96+$6060.80MAFFCF
7$45,336,308,493$38,851,223,944.22$37,948$5,265.87+$45336.27MAFFCF
8$320,113,259,536$271,603,409,448.44$50,795$8,596.74+$320113.21MAFFCF
9$2,134,813,939,431$1,792,292,751,727.42$71,034$14,549.41+$2134813.87MAFFCF
10$13,454,980,456,275$11,170,729,541,083.21$104,715$25,725.73+$13454980.35MAFFCF

AFFCF vs ABBV: Complete Analysis 2026

AFFCFStock

American Future Fuel Corporation, a resource company, engages in the acquisition, exploration, and development of alternative energy projects. It holds a 100% interest in the Ceboletta uranium project, which includes a mineral lease that comprises approximately 6,700 acres of mineral rights and 5,700 acres of surface rights located in west-central New Mexico. The company is headquartered in Vancouver, Canada.

Full AFFCF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this AFFCF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AFFCF vs SCHDAFFCF vs JEPIAFFCF vs OAFFCF vs KOAFFCF vs MAINAFFCF vs JNJAFFCF vs MRKAFFCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.